Post-translational Modifications: A New Perspective on the Pathogenesis of Atrial Cardiomyopathy

Area of Science:

• Cardiovascular Medicine
• Molecular Biology
• Biochemistry

Background:

• Atrial cardiomyopathy (AtCM) is a distinct cardiovascular disease involving atrial remodeling and dysfunction, linked to atrial fibrillation and stroke.
• Key features of AtCM include atrial myopathy and fibrosis, driven by complex interacting mechanisms.
• Post-translational modifications (PTMs) are crucial regulators of protein function and are implicated in AtCM pathogenesis.

Purpose of the Study:

• To review the role of various PTMs, including phosphorylation, acetylation, and ubiquitination, in the development of AtCM.
• To explore the potential clinical applications of understanding PTMs in AtCM.
• To identify future research directions in AtCM and PTMs.

Main Methods:

• Literature review of studies investigating PTMs in atrial cardiomyopathy.
• Analysis of the impact of specific PTMs (phosphorylation, acetylation, ubiquitination) on atrial structure and function.
• Synthesis of current knowledge on PTMs' role in AtCM pathogenesis.

Main Results:

• Phosphorylation, acetylation, and ubiquitination are significantly involved in the molecular mechanisms underlying AtCM.
• PTMs influence key pathological processes such as atrial fibrosis and myopathy.
• Evidence suggests PTMs are critical determinants of AtCM progression and severity.

Conclusions:

• PTMs play a pivotal role in the pathophysiology of atrial cardiomyopathy.
• Targeting PTMs offers promising avenues for novel AtCM diagnostics and therapeutics.
• Further research is needed to fully elucidate PTM functions and clinical utility in AtCM.